Key result
Peripartum cardiomyopathy requires echocardiographic diagnosis and multidisciplinary management during late pregnancy or early postpartum.
This narrative review provides a comprehensive overview of peripartum cardiomyopathy, emphasizing the critical role of echocardiography in diagnosis and the need for multidisciplinary management tailored to pregnancy and lactation.
Reinforces echocardiography and multidisciplinary care standards in peripartum cardiomyopathy; leaves open need for etiology-specific therapies.
Peripartum cardiomyopathy (PPCM) is a rare, idiopathic, and often dilated cardiomyopathy that is marked by systolic dysfunction that presents in late pregnancy or the early postpartum period. A workshop convened by the US National Heart, Lung, and Blood Institute (NHLBI) in the 1990s defined PPCM as heart failure that develops in the last month of pregnancy or up to five months postpartum with left ventricular systolic dysfunction. Prior to the availability of echocardiography, diagnosis was based only on clinical findings. Recently, the inclusion of echocardiography has made diagnosis of PPCM easier and more accurate. Etiopathogenesis is still poorly understood, but recent evidence supports inflammation, viral infection, and autoimmunity as the leading causative hypotheses. Eastern Med Coll J. July 2023; 8 (2):68-74
No takes yet. Share an insight, caveat, or question.
Arzoo et al. (2023) conducted a review in Peripartum Cardiomyopathy. Peripartum cardiomyopathy is a rare, idiopathic dilated cardiomyopathy presenting in late pregnancy or early postpartum that requires echocardiographic diagnosis and multidisciplinary management.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: